AP NEWS
ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
Related topics
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Adamas to Present at Upcoming SVB Leerink CNS Forum

June 23, 2021 GMT

EMERYVILLE, Calif.--(BUSINESS WIRE)--Jun 23, 2021--

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that the company will present “What’s Happening in Parkinson’s Disease & the GOCOVRI Opportunity” at the SVB Leerink CNS Forum on Tuesday, June 29 th at 1:10 pm Eastern Time.

The presentation will be broadcast live from the investor relations section of the Adamas website at http://ir.adamaspharma.com/events-presentations. Replays of the event will be available for 30 days.

ADVERTISEMENT

About Adamas Pharmaceuticals, Inc.

At Adamas our vision is clear – to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and, society. We are a fully-integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. For more information, please visit www.adamaspharma.com.

Source: Adamas Pharmaceuticals, Inc.

View source version on businesswire.com:https://www.businesswire.com/news/home/20210623005941/en/

CONTACT: Media:

Sarah Mathieson

Vice President, Corporate Communications

510-450-3528

smathieson@adamaspharma.com

Investors:

Peter Vozzo

Managing Director

Westwicke/ICR

443-213-0505

peter.vozzo@westwicke.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH

SOURCE: Adamas Pharmaceuticals, Inc.

Copyright Business Wire 2021.

PUB: 06/23/2021 04:42 PM/DISC: 06/23/2021 04:42 PM

http://www.businesswire.com/news/home/20210623005941/en